FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation.
about
Mesenchymal stem cells engineered to inhibit complement-mediated damage.Xenotransplantation literature update September-October 2004.Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall.Flow cytometry and the future of vaccine development.Human thrombomodulin regulates complement activation as well as the coagulation cascade in xeno-immune response.Optimization of cytotoxicity assay by real-time, impedance-based cell analysis.
P2860
FDA/PI flow cytometry assay of complement-mediated cytotoxicity of antibodies generated during xenotransplantation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
FDA/PI flow cytometry assay of ...... ed during xenotransplantation.
@en
type
label
FDA/PI flow cytometry assay of ...... ed during xenotransplantation.
@en
prefLabel
FDA/PI flow cytometry assay of ...... ed during xenotransplantation.
@en
P2093
P2860
P356
P1433
P1476
FDA/PI flow cytometry assay of ...... ed during xenotransplantation.
@en
P2093
Alberto Centeno
Dolores Ortega
Eduardo López
Nieves Doménech
Rafael Mañez
Sonia Pértega
Tomas M Díaz
P2860
P356
10.1002/CYTO.A.20076
P577
2004-11-01T00:00:00Z